
Keywords: فاکتور رشد اندوتلیال عروقی (VEGF); Bevacizumab; Trabecular meshwork; Schlemm's canal; Clearance; Intraocular pressure; Choroidal neovascularization; CNV; vascular endothelial growth factor; VEGF; age-related macular degeneration; AMD; intraocular pressure; IOP; trabecular meshwork; TM; Sch